 |
 |
|
|
|
 |
 |
 |
|
|
 Download
- instruction.pdf
1. MANUSCRIPT SUBMISSION. Submit manuscripts
according to guidelines in 3(b), below, to Dr. Ajay K.
Banga, Editor-in-Chief, Mercer University, Department of
Pharmaceutical Sciences, 3001 Mercer University Drive,
Atlanta, GA 30341-4155, USA; banga_ak@mercer.edu.
2. SCOPE,OBJECTIVES,AND EDITORIAL POLICY. Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, rheumatoid arthritis, HIV infection, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, and comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
3. PREPARATION OF MANUSCRIPTS.
- Write in clear, concise English. The author is responsible for all aspects of manuscript preparation. Extensive changes to the manuscript will not be undertaken by the Editor.
- Submit either (1) via email, a PDF of the manuscript, tables, and figures to the Editor, followed by one hard copy via mail; or (2) via mail, three (3) copies of the manuscript, which must be double-spaced and printed on US Letter or A4 paper. Text files must be submitted in Microsoft Word with all pages numbered consecutively, starting with the title page and ending with pages containing references, tables, and figure legends, which should be grouped with furnished art at the end. A diskette containing the text file must accompany final (accepted and reviewed) manuscripts, along with the revised and final hard copy.
- Include a statement that any animals used in investigations have been cared for according to the Animal Rights Act and the NIH Guide for Care and Use of Laboratory Animals.
- A confict-of-interest statement is required with each manuscript. This statement will have no bearing on the editorial decision regarding publication of the manuscript. Use one of the following statements: (1) "The author or one or more of the authors has/have received or will receive benefits from a commercial party related directly or indirectly to the subject matter of this article." (2) "No benefits have been or will be received from a commercial party related directly or indirectly to the subject matter of this article."
- A signed statement attesting to the following must accompany the submission: "The undersigned author(s) transfer(s) all copyright ownership of the manuscript (title of article) to Critical Reviews™ in Therapeutic Drug Carrier Systems in the event the work is published.The undersigned author(s) warrant(s) that the article is original, does not infringe upon any copyright or proprietary right of any third party, is not under consideration by any other journal, and has not been previously published. The final manuscript has been read, and each author's contribution has been approved by the appropriate author."
- All manuscripts must include the following:
Author contact information. Corresponding author's full name, affiliation, email address, telephone number, fax number, and complete mailing address; full names and affiliations for all additional authors.
Abstract/Key Words. All manuscripts should be accompanied by an abstract not to exceed 500 words as well as a list of three to six key words (not used in the title) to assist in cross-indexing your article.
Text. In addition to the main body of text, reviews should include an Introduction or Historical Background, Summary/Conclusions, and, if applicable, Acknowledgments. Number sections according to the following scheme:
I. PRINCIPAL HEADING
I.A. First Subheading
1. Second Subheading
a. Third Subheading
Italic or boldface type should be clearly indicated, and Greek or unusual characters should be written plainly or explained by annotations.
4. TABLES. Tables should be used only when they can
present information more effectively than can be done in
running text. Avoid any arrangement which unduly increases the depth of a table, and the column heads should be made as brief as possible, using abbreviations liberally. Lines of data should not be numbered nor run numbers given unless those numbers are needed for reference in the text. Columns should not be used to contain only one or two entries, nor should the same entry be repeated numerous times consecutively.
5. ILLUSTRATIONS. Figures should be numbered in
series, and all legends should be typed double-spaced on
a separate sheet. Both figures and captions should be
grouped at the end of the manuscript. Symbols (open or
closed circles, triangles, squares) and lettering should be
sized for optimum reproduction at a maximum width of 5"
(8" for landscape). Color reproduction of figures is possible at the author's expense. Rates for color printing will be furnished upon request. All illustrative material should be mailed flat and protected by heavy cardboard, free of clips and staples.
- Line drawings, graphs, and photographs should be provided in electronic format.
Copyrighted Material. Authors who want to make use of artwork already published, or verbatim quotations of text amounting to more than a few words, are required by copyright law to ask the owner of the copyright (usually the publisher) for permission. Assign proper credit in the caption (the copyright holder may specify wording). Send copies of permissions clearly marked to indicate the relevant figure or table. If authors use material from their own published work, permission must be obtained from the publisher.
6. FORMULAE AND EQUATIONS. Empirical and structural formulae and mathematical and chemical equations should be arranged to proportionally fit a width of 5”. Subscripts and especially superscripts (i.e., exponents) should be written with care. All signs such as +, −, =, <, or > should be spaced, but the components of mathematical products should not be spaced. Organic structural formulæ should be submitted as copy suitable for direct photographic reproduction. Do not use structures when a simple formula will suffice. Do not use multiple lines unnecessarily; format simple fractional expressions with a slant so they can be set on a single line. To avoid errors, carefully arrange and execute all formula matter with special attention to correctness of symbols, location of subscripts, superscripts, and electric charges, and the placing and close join-up of single and multiple bond lines. Use a copy of the structure in the text at the point of proper citation, but when originals are provided, group these at the end of the manuscript. All furnished art must be complete.
7. OFFPRINTS. Forms and instructions for ordering offprints, copies of issues, and subscriptions will be included with the page proofs sent to authors.
REFERENCES.
Critical Reviews™ in Therapeutic Drug Carrier Systems uses the Vancouver Style for all references. This style is available in all commonly used reference management programs and style manuals. No manuscript will be accepted for publication unless the references are correctly formatted, as follows.
References to the literature or other bibliographic notes must be numbered consecutively in the text, avoiding repetition by using the number that corresponds to the original reference. Reference numbers are typed as unparenthesized superscripts following either the author name(s) or the sentence or clause containing the referenced material.
Place numbers after all punctuation with no space between. List names of all authors up to nine, using "et al." for the tenth and all following authors.
Bibliographic references to classifed documents and reports or to unpublished material not generally available to the scientific public should not be used.
Following are samples of reference formatting:
Journal Articles
2. Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E. Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer 1996; 73:1006−12.
Books
1. Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2 ed. Albany NY: Delmar, 1996.
Chapter in edited work
1. Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465−78.
Conference proceedings
1. Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology; 95 Oct 15−19; Kyoto, Japan. Amsterdam: Elsevier, 1996.
|
|
|
 |
|
 |
|
|
|
Login
Register
Home
Books
Journals
References
A-Z
Index
Author
Index
User Area
Shopping Cart
Contact
Critical Reviews™ in Therapeutic Drug Carrier Systems
